BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21137606)

  • 1. Acute generalized exanthematous pustulosis.
    Pecina JL; Cappel MA
    Skinmed; 2010; 8(4):210-4. PubMed ID: 21137606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis (AGEP): A review and update.
    Szatkowski J; Schwartz RA
    J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalised exanthematous pustulosis.
    Fernando SL
    Australas J Dermatol; 2012 May; 53(2):87-92. PubMed ID: 22571555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts.
    Speeckaert MM; Speeckaert R; Lambert J; Brochez L
    Eur J Dermatol; 2010; 20(4):425-33. PubMed ID: 20542841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CME. Severe cutaneous drug reaction].
    Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
    Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
    [No Abstract]   [Full Text] [Related]  

  • 8. A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine.
    Duckworth L; Maheshwari MB; Thomson MA
    Clin Exp Dermatol; 2012 Jan; 37(1):24-7. PubMed ID: 21790726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized acute generalized exanthematous pustulosis with amoxicillin and clavulanic acid.
    Ozkaya-Parlakay A; Azkur D; Kara A; Yildiz Y; Orhan D; Cengiz AB; Ersoy-Evans S
    Turk J Pediatr; 2011; 53(2):229-32. PubMed ID: 21853667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute generalized exanthematous pustulosis. Study of 22 cases].
    Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
    Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is acute generalized exanthematous pustulosis an uncommon condition in childhood?
    Ozmen S; Misirlioglu ED; Gurkan A; Arda N; Bostanci I
    Allergy; 2010 Nov; 65(11):1490-2. PubMed ID: 20486903
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of amoxycillin-induced follicular acute localised exanthematous pustulosis.
    Rajgopal Bala H; Jalilian C; Goh MS; Williams R; Tan G; Chong AH
    Australas J Dermatol; 2017 Feb; 58(1):e23-e25. PubMed ID: 26552363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis (AGEP), presenting with toxic epidermal necrolysis-like features, due to morphine: a neglected culprit?
    Kardaun SH
    Eur J Dermatol; 2011; 21(3):427-8. PubMed ID: 21515438
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous vasculitis overlap with acute generalised exanthematous pustulosis (AGEP).
    Murad A; Murphy A
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25404248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis or toxic epidermal necrolysis?
    Suárez-Amor O; Cabanillas M; Monteagudo B; Ramírez-Santos A; Pérez-Valcárcel J; De Las Heras C
    Pediatr Dermatol; 2010; 27(5):559-60. PubMed ID: 21182651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute generalized exanthematous pustulosis].
    Comstedt LR; Gregersen JH; Bygum A
    Ugeskr Laeger; 2010 Feb; 172(8):628-9. PubMed ID: 20184822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug eruptions: the value of oral rechallenge test and patch test.
    Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
    J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23.
    Sakuragi Y; Sawada Y; Hara Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Acta Derm Venereol; 2016 Feb; 96(2):265-6. PubMed ID: 26302837
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime.
    Chaabane A; Aouam K; Gassab L; Njim L; Boughattas NA
    Fundam Clin Pharmacol; 2010 Aug; 24(4):429-32. PubMed ID: 19925632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.